Bryan Gilburg - China

“Manufacturers using chemicals included in the list will need to submit annual usage reports to the TFDA.”

Bryan Gilburg

Managing Director

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

The Thai FDA Updates List of Chemical Pollutants

Published on: August 25th, 2021

Manufacturers Will Need to Report Usage of Certain Chemicals

As chemical pollutants become a growing concern, The Thai FDA has released a document to have medical device regulations comply with the Stockholm Convention on Persistent Organic Pollutants. This announcement establishes rules for gathering reports on chemical substances usage, indicated in the chart below. The full announcement can be found here.

If any of these chemicals are used, the amount of usage should be reported to the Thai FDA at mdregulation@fda.moph.go.th beginning September 2021.

CAS No. 335 -67-1 Perfluorooctanoic acid (PFOA
CAS No. 3825-26-1 Ammonium Perfluorooctanoate
CAS No. 334-95-5 Sodium Perfluorooctanoate
CAS No. 2395-00-8 Potassium Perfluorooctanoate
CAS No. 335-93-3 Silver Perfluorooctanoate
CAS No. 335-66-0 Perfluorooctanoyl Fluoride
CAS No. 376-27-2 Methyl Perfluorooctanoate
CAS No. 3108-24-5 Ethyl Perfluorooctanoate

Come Grow with Us

Asia Actual has offices in Bangkok, and throughout Southeast Asia, staffed by experienced, bilingual regulatory and commercial professionals to address any questions or provide support.  Please contact us if you need regulatory support in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Hong Kong Refines Medical Device Post-Market Surveillance Report Form

On December 29th, 2022, the Hong Kong Medical Device Division refined and updated their Post-Market Surveillance Report form.

Thailand FDA Provides Guidance on Classification of Physical Therapy Devices

On December 3rd, 2022, the Thailand FDA (TFDA) issued new regulation to re-classify Physical Therapy Devices as Class 1 medical devices.

Philippines FDA Issues Advisory Reiteration Against Unethical Business Practices

On December 29th, 2022 the Philippines FDA (PFDA) issued an advisory reiteration concerning unethical business practices, specifically in regards to companies that sell/manufacture Prescription Pharmaceutical Products and Medical Devices (PPPMD) and their relationship/interaction with healthcare professionals (HCPs).